Wellington Management Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-81,971
Closed -$1.1M 2066
2023
Q1
$1.1M Sell
81,971
-2,492
-3% -$43.1K ﹤0.01% 1632
2022
Q4
$1.04M Sell
84,463
-4,949
-6% -$70.1K ﹤0.01% 1628
2022
Q3
$1.25M Sell
89,412
-4,964
-5% -$79.9K ﹤0.01% 1614
2022
Q2
$1.3M Hold
94,376
﹤0.01% 1622
2022
Q1
$1.54M Sell
94,376
-1,229
-1% -$19.3K ﹤0.01% 1653
2021
Q4
$1.56M Buy
+95,605
New +$1.61M ﹤0.01% 1720
2020
Q1
Sell
-272,893
Closed -$33.8M 2084
2019
Q4
$33.8M Buy
272,893
+249,521
+1,068% +$22.3M 0.01% 856
2019
Q3
$1.55M Buy
23,372
+5,788
+33% +$389K ﹤0.01% 1646
2019
Q2
$1.4M Buy
17,584
+12,635
+255% +$1.13M ﹤0.01% 1700
2019
Q1
$553K Buy
+4,949
New +$541K ﹤0.01% 1883
2018
Q3
Sell
-5,816
Closed -$488K 2338
2018
Q2
$488K Buy
+5,816
New +$426K ﹤0.01% 2047
2014
Q4
Sell
-1,600
Closed -$379K 2261
2014
Q3
$379K Sell
1,600
-300
-16% -$76.5K ﹤0.01% 2044
2014
Q2
$450K Sell
1,900
-8,115
-81% -$2.14M ﹤0.01% 1992
2014
Q1
$3.3M Buy
+10,015
New +$3.38M ﹤0.01% 1573
2013
Q3
Sell
-81,000
Closed -$3.63M 2248
2013
Q2
$3.63M Buy
+81,000
New +$2.77M ﹤0.01% 1505

Other funds holding ICPT

Wellington Management Group's ICPT Position: Q2 2023 in Review

Wellington Management Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 81,971 shares — an estimated $1.1M sold.

Wellington Management Group first reported a position in ICPT in Q2 2013 and held it in 15 quarters. The position peaked at $33.8M in Q4 2019. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

  • Wellington Management Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Wellington Management Group sold 81,971 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $1.1M.
  • Wellington Management Group first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 15 quarters.
  • Wellington Management Group's Intercept Pharmaceuticals, Inc. position peaked at $33.8M in Q4 2019.
  • 126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.